Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...